Download STIs in Boston: Gonorrhea Brief 2014

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Traveler's diarrhea wikipedia , lookup

Trichinosis wikipedia , lookup

Gastroenteritis wikipedia , lookup

Hepatitis C wikipedia , lookup

Pandemic wikipedia , lookup

Oesophagostomum wikipedia , lookup

Coccidioidomycosis wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Middle East respiratory syndrome wikipedia , lookup

Eradication of infectious diseases wikipedia , lookup

Sexually transmitted infection wikipedia , lookup

Transcript
STIs in Boston: Gonorrhea Brief 2014
Gonorrhea is the second most commonly
reported sexually transmitted infection (STI)
and one of the top five most commonly
reported communicable diseases in Boston.
There were over 300,000 cases of gonorrhea
reported in the US in 2013 (Centers for Disease
Control & Prevention, CDC).
Boston Epidemiology:
In 2014, there were 928 cases of gonorrhea
reported in Boston (150 cases per 100,000). The
citywide rate was 1.4 times as high as the most
recent national rate (106.7 per 100,000 in 2013,
the most recent CDC data available).
High Risk Groups:
Rates were particularly high in men of color
ages 20 to 29 living in Mattapan, North
Dorchester, South Dorchester, Roxbury, and the
South End.
Unlike chlamydia where rates are higher in
women, men accounted for 66% of reported
gonorrhea cases in Boston.
For race/ethnicity analyses, Latino ethnicity is
considered alongside Asian, Black, and White
racial groups. In 2014, Black residents had the
highest incidence rate with 343 cases per
100,000. This rate was over 4 times as high as
that of White residents. Latino residents had a
rate 1.3 times as high as that of White
residents. Gonorrhea rates were lowest in Asian
residents.
Gonorrhea rates were highest in residents 1529 years old, with 69% of all cases occurring in
this age group (300 cases per 100,000). White
residents were diagnosed at a significantly older
age (Median ages at diagnosis: White=29,
Latino=24, Black=23). The median age at
diagnosis for men was 5 years older than the
median age for women (27 vs. 22, respectively).
Disparities by race were more pronounced in
20-24 year olds; the rates in Black and Latino
residents were 15 and 3 times that of White
residents in this age group, respectively.
The incidence rate was highest in the South End
(310 cases per 100,000). North Dorchester,
South Dorchester, Mattapan, and Roxbury all
had rates higher than 200 cases per 100,000.
Mattapan and South Dorchester had rates
higher than 800 cases per 100,000 in residents
15-29 years old.
In 2014, 25% of all people diagnosed with
gonorrhea were also diagnosed with chlamydia
at some point during the year. Most were men
(59%), and 56% were Black residents. The
majority of cases with both infections resided in
North Dorchester, South Dorchester, the South
End, and Mattapan, and 75% were 15-29 years
old.
Future Directions:
While the rate of chlamydia infection in Boston
is four times as high as the rate of gonorrhea,
the high gonorrhea rate is of particular concern
in light of the rise in antibiotic resistant
gonorrhea nationwide. Populations at high risk
for gonorrhea are not necessarily the same
populations at high risk for chlamydia,
indicating that outreach methods need to vary.
Early detection and treatment of gonorrhea
cases and their partners as well as initiatives to
promote safer sex are important to decrease
the number of gonorrhea cases.
Map 1
Data:
Data for this report were collected and analyzed
by BPHC.
Gonorrhea data from 2008 to 2014 are available
online at http://bphc.org/healthdata/otherreports/Pages/Other-Reports.aspx. Please
note: Due to a change in the gonorrhea data
Map 2
source, BPHC cautions against drawing
comparisons of 2014 gonorrhea data to
analyses completed prior to 2014.
Additional information about gonorrhea in
Boston can be obtained by emailing
[email protected] or by calling the
BPHC Infectious Disease Bureau at (617) 5345611.